FDA.reportPublic FDA data

Nucala 100 MG in 1 mL Auto-Injector

RxCUI
2170993
RxNorm name
Nucala 100 MG in 1 mL Auto-Injector
Display name
Nucala 100 MG in 1 mL Auto-Injector
Full name
Nucala 100 MG in 1 mL Auto-Injector
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:30

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125526Nucalamepolizumab351(a)Rx2026-06-01
761122Nucalamepolizumab351(a)Rx2026-06-01

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
fefb887c-e4ac-431e-8893-e9d1a5a63feaNucala 100 MG in 1 mL Auto-InjectorPSN24These highlights do not include all the information needed to use NUCALA safely and effectively. See full prescribing information for NUCALA. NUCALA (mepolizumab) for injection, for subcutaneous use NUCALA (mepolizumab) injection, for subcutaneous use Initial U.S. Approval: 201520250806
fefb887c-e4ac-431e-8893-e9d1a5a63feaNucala 100 MG per 1 ML Auto-InjectorSY24These highlights do not include all the information needed to use NUCALA safely and effectively. See full prescribing information for NUCALA. NUCALA (mepolizumab) for injection, for subcutaneous use NUCALA (mepolizumab) injection, for subcutaneous use Initial U.S. Approval: 201520250806
fefb887c-e4ac-431e-8893-e9d1a5a63fea1 ML mepolizumab 100 MG/ML Auto-Injector [Nucala]SBD24These highlights do not include all the information needed to use NUCALA safely and effectively. See full prescribing information for NUCALA. NUCALA (mepolizumab) for injection, for subcutaneous use NUCALA (mepolizumab) injection, for subcutaneous use Initial U.S. Approval: 201520250806
fefb887c-e4ac-431e-8893-e9d1a5a63fea1 ML Nucala 100 MG/ML Auto-InjectorSY24These highlights do not include all the information needed to use NUCALA safely and effectively. See full prescribing information for NUCALA. NUCALA (mepolizumab) for injection, for subcutaneous use NUCALA (mepolizumab) injection, for subcutaneous use Initial U.S. Approval: 201520250806